Thiamine Supplementation in Progressive Supranuclear Palsy
Patients with PSP should be screened for thiamine deficiency and supplemented if deficiency is identified or strongly suspected, because PSP symptoms overlap extensively with Wernicke's encephalopathy and superimposed thiamine deficiency can dramatically worsen pre-existing PSP symptoms—yet routine prophylactic supplementation is not indicated in well-nourished PSP patients without risk factors. 1
Clinical Rationale for Screening
The classic triad of PSP—postural instability, supranuclear vertical gaze palsy, and dementia—overlaps almost completely with Wernicke's encephalopathy symptoms (cognitive impairment, gait problems, and ocular abnormality). 1 This overlap creates a diagnostic trap where worsening symptoms may be attributed to PSP progression when they actually represent superimposed, reversible thiamine deficiency. 1
A documented case demonstrates that a 64-year-old woman with established PSP who fulfilled both PSP diagnostic criteria and Caine's criteria for Wernicke's encephalopathy experienced marked improvement in symptoms present for 2-3 years after thiamine supplementation, despite these symptoms being originally presumed irreversible PSP manifestations. 1 This case establishes that PSP may be a risk factor for thiamine deficiency and that supplementation can reverse symptoms previously attributed to neurodegenerative disease. 1
When to Supplement: Risk-Stratified Algorithm
High-Risk PSP Patients (Supplement Immediately)
Administer 100-300 mg IV thiamine daily without waiting for laboratory confirmation if any of the following are present: 2
- Malnutrition or unintentional weight loss >10% over 3-6 months 2
- Dysphagia with inadequate oral intake for >5-10 days 2
- Alcohol use disorder (30-80% have thiamine deficiency) 2
- Prolonged vomiting or feeding difficulties 2
- Acute worsening of gait, cognition, or eye movements beyond expected PSP progression 1
- Unexplained lactic acidosis or cardiovascular dysfunction 2
Critical timing: Give thiamine before any glucose-containing IV fluids to prevent precipitating acute Wernicke's encephalopathy. 2
Moderate-Risk PSP Patients (Screen and Supplement if Low)
Measure red blood cell or whole blood thiamine diphosphate (ThDP)—not plasma thiamine—in patients with: 2
- BMI <18.5 kg/m² 2
- Chronic diuretic therapy (6% of heart failure patients are deficient) 2
- Progressive dysphagia requiring modified diet 3, 4
- Recent hospitalization or critical illness 2
If thiamine level is low or clinical signs of deficiency are present, prescribe oral thiamine 100-300 mg daily for 2-3 months. 2 If absorption is questionable due to severe dysphagia, use 100-300 mg IV or IM daily. 2
Low-Risk PSP Patients (No Routine Supplementation)
Well-nourished PSP patients eating adequately without the above risk factors do not require routine prophylactic thiamine beyond standard dietary intake (1.1-1.2 mg/day). 5 Standard multivitamins containing 1-3 mg thiamine are sufficient for maintenance in this population. 2
Dosing Protocol by Clinical Scenario
| Clinical Situation | Route | Dose | Duration |
|---|---|---|---|
| Suspected Wernicke's encephalopathy superimposed on PSP | IV | 500 mg three times daily | 3-5 days, then transition to oral [2] |
| High-risk PSP with malnutrition/dysphagia | IV/IM | 100-300 mg daily | Until risk factors resolve, then oral [2] |
| Confirmed deficiency, stable patient | Oral | 100-300 mg daily | 2-3 months [2] |
| Maintenance after deficiency resolution | Oral | 50-100 mg daily | Ongoing if risk factors persist [2] |
Common Pitfalls to Avoid
Do not assume all symptom progression is PSP. The neurodegenerative nature of PSP (mean survival 9 years from onset) 6 creates a bias toward attributing all worsening to disease progression, missing reversible thiamine deficiency. 1 Any acute or subacute worsening of the classic PSP triad warrants thiamine assessment. 1
Do not rely on standard multivitamins for treatment. These contain only 1-3 mg thiamine, which is inadequate for treating deficiency or high-risk states. 2 Therapeutic dosing requires 100-300 mg daily. 2
Do not wait for laboratory confirmation in high-risk patients. Thiamine reserves deplete within 20 days of inadequate intake, and treatment is safe with no established toxicity limit—excess is simply excreted in urine. 2, 5 The benefit-risk ratio overwhelmingly favors empiric treatment. 2
Do not use oral thiamine in patients with severe dysphagia or active vomiting. PSP commonly causes progressive dysphagia 3, 4, which impairs thiamine absorption. Use parenteral administration in these cases. 2
Monitoring and Safety
Thiamine supplementation carries minimal risk. High IV doses rarely cause anaphylaxis, and doses >400 mg may induce only mild nausea, anorexia, or mild ataxia. 2, 5 No upper toxicity limit has been established. 2, 5
If measuring thiamine status, use red blood cell or whole blood thiamine diphosphate (ThDP), as this is the only reliable marker and is unaffected by inflammation. 2 Plasma thiamine is not useful. 2
Clinical improvement—reduction in gait instability, improved cognition, or better eye movements—is the best indicator of response and may occur within days to weeks of supplementation. 1
Multidisciplinary Considerations
PSP requires multidisciplinary management including neurology, nutrition, speech therapy (for dysphagia), and physical therapy. 3, 4 The neuroscience nurse or primary clinician should maintain high suspicion for thiamine deficiency throughout the disease course, particularly as dysphagia progresses and nutritional intake declines. 3, 4